[Federal Register Volume 62, Number 120 (Monday, June 23, 1997)]
[Notices]
[Page 33889]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-16308]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Institute for
Occupational Safety and Health: Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following committee meeting:
Name: Board of Scientific Counselors, National Institute for
Occupational Safety and Health (BSC, NIOSH).
Time and Date: 9 a.m.-5 p.m., July 23, 1997.
Place: The Washington Court, Montpelier Room, 525 New Jersey
Avenue, NW, Washington, DC 20001-1527.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 50 people.
Purpose: The BSC, NIOSH is charged with providing advice to the
Director, NIOSH on NIOSH research programs. Specifically, the Board
shall provide guidance on the Institute's research activities
related to developing and evaluating hypotheses, systematically
documenting findings, and disseminating results.
Matters To Be Discussed: Agenda items include a report from the
Director of NIOSH; Final Report on the NIOSH Musculoskeletal
Disorders Research Program; International Standardization; Navy
Sarcoidosis Study; Health Effects Laboratory Division (HELD)
Activity Update; and future activities of the Board.
NIOSH/National Cancer Institute will present a protocol that has
been revised based on comments received from the BSC and the public
on the previous draft protocol for a study entitled ``A Cohort
Mortality Study with a Nested Case-Control Study of Lung Cancer and
Diesel Exhaust Among Non-Metal Miners' (``diesel study''). Copies of
the revised protocol may be obtained from Michael Attfield, Ph.D.,
NIOSH Project Director, NIOSH, Division of Respiratory Disease
Studies, Mail Stop 234, 1095 Willowdale Road, Morgantown, West
Virginia 26505-2888. Telephone 304/285-5751, e-mail mda1@cdc.gov.
Individuals will be permitted to make brief (10-minute) oral
statements subject to the availability of time. Persons who wish to
make oral statements should make a written request to the contact
person listed below.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Dr. Bryan D. Hardin,
Executive Secretary, NIOSH, Room 715-H, Hubert H. Humphrey Building,
200 Constitution Avenue SW, Washington, DC, 20201. Telephone 202/
205-8556, fax 202/260-4464, e-mail bdh1@cdc.gov.
Dated: June 17, 1997.
Nancy C. Hirsch,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 97-16308 Filed 6-20-97; 8:45 am]
BILLING CODE 4163-19-P
